We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

HIV and HCV Intervention In Drug Treatment Settings - 1

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00102349
First Posted: January 28, 2005
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Oregon Health and Science University
Information provided by:
National Institute on Drug Abuse (NIDA)
January 27, 2005
January 28, 2005
January 12, 2017
November 2004
February 2006   (Final data collection date for primary outcome measure)
HIV/HCV injection risk behaviors
Not Provided
Complete list of historical versions of study NCT00102349 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
HIV and HCV Intervention In Drug Treatment Settings - 1
HIV and HCV Intervention in Drug Treatment Settings
The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.
Not Provided
Interventional
Phase 3
Primary Purpose: Prevention
Behavior Therapy
Behavioral: Behavior Therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
706
February 2006
February 2006   (Final data collection date for primary outcome measure)
Volunteers will be IV drug users already enrolled in drug detoxification treatment.
Sexes Eligible for Study: All
18 Years to 99 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00102349
NIDA-CTN-0017-1
Yes
Not Provided
Not Provided
Robert Booth, Ph.D., University of Colorado at Denver
University of Colorado, Denver
Oregon Health and Science University
Principal Investigator: Robert Booth, Ph.D. University of Colorado, Denver
National Institute on Drug Abuse (NIDA)
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP